Last Price
25.45
Today's Change
+0.005 (0.01%)
Day's Change
25.43 - 25.46
Trading Volume
798,788
Market Cap
2 Billion
Shares Outstanding
86 Million
Avg Volume
1,725,329
Avg Price (50 Days)
17.95
Avg Price (200 Days)
14.84
PE Ratio
-11.52
EPS
-2.21
Earnings Announcement
07-Aug-2024
Previous Close
25.45
Open
25.46
Day's Range
25.43 - 25.46
Year Range
9.9 - 25.55
Trading Volume
799,130
1 Day Change
0.02%
5 Day Change
0.22%
1 Month Change
71.53%
3 Month Change
62.44%
6 Month Change
107.80%
Ytd Change
53.81%
1 Year Change
86.07%
3 Year Change
-26.26%
5 Year Change
5.49%
10 Year Change
44.22%
Max Change
44.22%
No result.
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Description:
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.